These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7455978)

  • 1. Evaluation of plasminogen and other fibrinolytic parameters in the amniotic fluid.
    Aznar J; Gilabert J; Estelles A; Parrilla JJ
    Thromb Haemost; 1980 Jun; 43(2):182. PubMed ID: 7455978
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasminogen and amniotic fluid].
    Revelli E; Pattarelli M; Panazzolo A; Scarpa F; Giordano G
    Minerva Ginecol; 1968 Jul; 20(13):1109-22. PubMed ID: 5706585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies of the components of the fibrinolytic system in the amniotic fluid].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Oct; 23(10):1193-205. PubMed ID: 4245051
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitors of fibrinolysis in amniotic fluid.
    Walker JE; Campbell DM; Ogston D
    Thromb Haemost; 1980 Aug; 44(1):32-4. PubMed ID: 6968460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible origin of amniotic fluid constituents influencing fibrinolytic activity.
    Pajor A; Gróf J; Menyhárt J
    Haematologia (Budap); 1984; 17(4):443-8. PubMed ID: 6532914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C3 component, fibrinogen and fibrin degradation products as well as plasminogen in amniotic fluid].
    Cisło M
    Pol Tyg Lek; 1978 Jan; 33(4):155-7. PubMed ID: 652636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of amniotic fluid fibrinolytic activity (author's transl)].
    Hernandez A; Parrilla JJ; Aznar J; Gilabert J; Estelles A
    Sangre (Barc); 1975; 20(2):108-12. PubMed ID: 124956
    [No Abstract]   [Full Text] [Related]  

  • 8. [On activators and inhibitors of fibrinolysis in the amniotic fluid and in extracts of the placenta, decidua and myometrium of interrupted and normally terminated pregnancies].
    Slunský R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):236-43. PubMed ID: 4174664
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasminogen activator and urokinase inhibitor in myometrium, placenta, and amniotic fluid.
    Uszyński M; Uszyński-Folejewska R
    Am J Obstet Gynecol; 1969 Dec; 105(7):1041-3. PubMed ID: 5352583
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolytic properties of uterine tissues and pathogenesis of hyperfibrinolysis in obstetrical thrombohemorrhagic syndrome].
    Skipetrov VP
    Vopr Okhr Materin Det; 1969 Mar; 14(3):69-75. PubMed ID: 5345831
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the question of activators of fibrinolysis in the amniotic fluid and in placental extracts of full-term pregnancies].
    Slunský R; Adamcová M
    Z Geburtshilfe Gynakol; 1967 Oct; 167(3):337-44. PubMed ID: 5597697
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the inhibitors of fibrinolysis in the amniotic fluid and in the placental extracts of full term pregnancies].
    Slunský R; Adamcová M
    Z Geburtshilfe Gynakol; 1967; 167(2):224-31. PubMed ID: 5590814
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
    Agarwal S; Joyner KA; Swaim MW
    Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of the inhibitor of plasminogen activation in the euglobulin test.
    Januszko T; Buluk K; Uszyńska-Folejewska R; Uszyński M
    Pol Med J; 1966; 5(4):914-9. PubMed ID: 5964912
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the activity of the fibrinolytic system by means of blood and euglobulin fibrinolysis].
    Januszko T; Górski J; Reutt H
    Pol Tyg Lek; 1968 May; 23(22):818-21. PubMed ID: 5667103
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amniotic fluid on coagulation and platelet function in pregnancy: an evaluation using thromboelastography.
    Harnett MJ; Hepner DL; Datta S; Kodali BS
    Anaesthesia; 2005 Nov; 60(11):1068-72. PubMed ID: 16229690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.